The dramatic combinatorial activity of DUSP6 and HER2 targeting on cellular viability was also evidenced by lack of cytoplasmic eosin staining of the MDA-MB-453 xenograft tumor after 24 d of treatment (Fig. 5F). Here, DUSP6 is linked to neoplasm.